These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36363579)

  • 21. [Analysis of the use of proton pump inhibitors in primary health care].
    Hernández-Arroyo MJ; Díaz-Madero A; Enríquez-Gutiérrez E; Teijeiro-Bermejo MC; Sáez-Rodríguez E; Gutiérrez-Martín MR
    Semergen; 2018; 44(5):316-322. PubMed ID: 29153640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
    Zeng W; Finlayson AE; Shankar S; de Bruyn W; Godman B
    BMC Health Serv Res; 2015 Jan; 15():11. PubMed ID: 25609265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The general practitioner's knowledge and attitude towards proton pump inhibitors adverse effects].
    Rudelle K; Laroche ML
    Therapie; 2020; 75(3):253-260. PubMed ID: 31471066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
    Kurlander JE; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Zikmund-Fisher BJ; Yang YX; Laine L; Weissman A; Saini SD
    Am J Gastroenterol; 2020 May; 115(5):689-696. PubMed ID: 32091419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital.
    Ramirez E; Lei SH; Borobia AM; Piñana E; Fudio S; Muñoz R; Campos A; Carcas AJ; Frias J
    Curr Clin Pharmacol; 2010 Nov; 5(4):288-97. PubMed ID: 20925644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inappropriate Medication Use and Cost Comparison Analysis of Proton Pump Inhibitors: Evidence from an Indian Tertiary Care Facility.
    Venkataraman R; Rashid M; Shrestha H
    Curr Drug Saf; 2020; 15(2):147-155. PubMed ID: 32160850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concordance between use of proton pump inhibitors and prescribing guidelines.
    Pillans PI; Kubler PA; Radford JM; Overland V
    Med J Aust; 2000 Jan; 172(1):16-8. PubMed ID: 10682010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US.
    Rane PP; Guha S; Chatterjee S; Aparasu RR
    Res Social Adm Pharm; 2017; 13(2):358-363. PubMed ID: 27033427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage.
    Godman B; Fadare J
    Curr Med Res Opin; 2017 Nov; 33(11):2085-2087. PubMed ID: 28724310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
    Targownik LE; Fisher DA; Saini SD
    Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison.
    Yu SY; Lee B; McGuire TM; Lee HJ; Hollingworth SA
    Eur J Clin Pharmacol; 2020 Apr; 76(4):547-555. PubMed ID: 31822956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescribing PPIs.
    Drug Ther Bull; 2017 Oct; 55(10):117-120. PubMed ID: 29021249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study.
    Abrahami D; McDonald EG; Schnitzer M; Azoulay L
    BMJ Open; 2020 Dec; 10(12):e041529. PubMed ID: 33293322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence.
    Solem C; Mody R; Stephens J; Macahilig C; Gao X
    J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis.
    Gisbert JP; Khorrami S; Calvet X; Pajares JM
    Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):89-99. PubMed ID: 15095858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of proton pump inhibitors prescriptions in a tertiary care hospital in Lebanon.
    Souaid CK; Maalouf RG; Hallit S; Akiki B; Dagher E
    Arab J Gastroenterol; 2020 Sep; 21(3):194-198. PubMed ID: 32830092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicians' perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns.
    Awad A; Al-Tunaib A; Al-Saraf S
    Front Pharmacol; 2024; 15():1383698. PubMed ID: 38989150
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rise and rise of proton pump inhibitor drugs: patients' perspectives.
    Boath EH; Blenkinsopp A
    Soc Sci Med; 1997 Nov; 45(10):1571-9. PubMed ID: 9351147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.
    Giannini EG; Crespi M; Djahandideh A; Demarzo MG; Moscatelli A; Bodini G; Furnari M; Marabotto E; Plaz Torres MC; Zentilin P; Savarino V
    Dig Liver Dis; 2020 Aug; 52(8):862-868. PubMed ID: 32505566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.